Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment

Nefrologia (Engl Ed). 2024 Apr 16:S2013-2514(24)00062-2. doi: 10.1016/j.nefroe.2024.03.004. Online ahead of print.NO ABSTRACTPMID:38631964 | DOI:10.1016/j.nefroe.2024.03.004
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Authors: Source Type: research